佳力圖(603912.SH)副總經理葉莉莉累計減持3.6995萬股
格隆匯12月31日丨佳力圖(603912.SH)公佈,截止本公告披露日,公司副總經理、財務總監葉莉莉持有公司股票31.8萬股,約佔公司總股本2.17億股的0.1466%,其中持有的6.72萬股已於2019年4月17日解除限售並上市流通。
公司於2019年10月31日披露了《關於董事及高級管理人員減持股份計劃公告》,其中副總經理、財務總監葉莉莉計劃於2019年11月22日至2020年4月20日以集中競價方式減持4.2萬股,截止本公告日,集中競價交易減持數量過半,副總經理、財務總監葉莉莉通過集中競價方式減持公司股份3.6995萬股,佔公司總股本0.0171%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.